Back to BlackRock, Inc. BlackRock, Inc.

LXRXLXRX
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in LEXICON PHARMACEUTICALS INC

BlackRock, Inc. holds 17.3M shares of LXRX (LEXICON PHARMACEUTICALS INC), worth $41.6M as of 2026-Q2. The position was increased (+422.2% shares). LXRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$41.6M

Current Shares

17.3M

Total Value Change

+$25.7M

Total Shares Change

+7.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
17.3M
+422.2%
$41.6M0.0%$2.40
47
2026-Q1
Increased
3.3M
+4.1%
$5.2M0.0%$1.56
28
2025-Q4
Decreased
3.2M
-6.0%
$3.7M0.0%$1.15
0
2025-Q3
Increased
3.4M
+1.2%
$4.6M0.0%$1.35
27
2025-Q2
Decreased
3.4M
-66.5%
$3.2M0.0%$0.95
0
2025-Q1
Decreased
10M
-3.1%
$4.6M0.0%$0.46
0
2024-Q4
Increased
10.3M
+2.0%
$7.6M0.0%$0.74
28
2024-Q3
First report
10.1M
-
$15.9M0.0%$1.57
0

Other major holders of LXRX: FMR LLC, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used